Berger Financial Group’s Editas Medicine EDIT Stock Holding History

Berger Financial Group’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,300	Closed	-$218K	–	257
2021 Q3	$218K	Hold	5,300	–	–	0.04%	197
2021 Q2	$300K	Hold	5,300	–	–	0.05%	159
2021 Q1	$223K	Hold	5,300	–	–	0.05%	179
2020 Q4	$372K	Buy	+5,300	New	+$218K	0.07%	147

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berger Financial Group's EDIT Position: Q4 2021 in Review

Berger Financial Group sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 5,300 shares — an estimated $218K sold.

Berger Financial Group first reported a position in EDIT in Q4 2020 and held it in 4 quarters. The position peaked at $372K in Q4 2020. 305 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

Berger Financial Group reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
Berger Financial Group sold 5,300 Editas Medicine shares in Q4 2021, an estimated $218K.
Berger Financial Group first reported a position in Editas Medicine in Q4 2020 and held it in 4 quarters.
Berger Financial Group's Editas Medicine position peaked at $372K in Q4 2020.
305 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on Berger Financial Group's 13F filing for Q4 2021, filed 26 Jan 2022.